Waters Corporation WAT
433.54
3.24
0.75%
as of 25 Sep
- Market cap
- $42.3B
- P/E
- 108×
Follow WAT
Indexes
indicate stock being part of an index,
Insider Buys
alert about insiders buying in the last 12 month
Waters Corporation (WAT) Shares outstanding
Waters Corporation's shares outstanding at the end of fiscal 2025 was $59.7M, unchanged from fiscal 2024. At the end of the quarter to 30 June 2026 it was $98.2M. Over the past ten years it has ranged from $59.3M (fiscal 2023) to $83.1M (fiscal 2015); the current reading is higher than 27% of that period. Waters Corporation ranks 18th of 52 Diagnostics & Research companies by shares outstanding.
Shares outstanding, annual
Annual
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $59.7M | 0.26% |
| FY2024 | $59.6M | 0.48% |
| FY2023 | $59.3M | (1.76%) |
| FY2022 | $60.3M | (2.74%) |
| FY2021 | $62.0M | (0.62%) |
| FY2020 | $62.4M | (8.44%) |
| FY2019 | $68.2M | (12.18%) |
| FY2018 | $77.6M | (3.70%) |
| FY2017 | $80.6M | (1.00%) |
| FY2016 | $81.4M | (2.01%) |
Quarterly
| Period | Shares outstanding | Change |
|---|---|---|
| Jun 2026 | $98.2M | 19.56% |
| Mar 2026 | $82.1M | 37.57% |
| Dec 2025 | $59.7M | 0.14% |
| Sep 2025 | $59.6M | (0.06%) |
| 42 more quarters | Free account |
Against its own ten years
Low $59.3M
High $83.1M
Ten-year median
$62.4M
Current reading's percentile
27
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| A Agilent Technologies, Inc. compare | $283.0M |
| IQV IQVIA Holdings Inc. compare | $167.3M |
| ILMN Illumina, Inc. compare | $153.0M |
| NTRA Natera, Inc. compare | $143.3M |
| GH Guardant Health, Inc. compare | $132.9M |
| DGX Quest Diagnostics Incorporated compare | $112.0M |
| WAT Waters Corporation | $98.2M |
| IDXX IDEXX Laboratories, Inc. compare | $79.3M |
| MTD Mettler-Toledo International, Inc. compare | $20.2M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on WAT
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- The full statement